Tempest Therapeutics
TPST
#9881
Rank
NZ$43.01 M
Marketcap
$0.95
Share price
3.95%
Change (1 day)
-85.77%
Change (1 year)

EPS for Tempest Therapeutics (TPST)

EPS in 2023 (TTM): -$3.91

According to Tempest Therapeutics's latest financial reports the company's current EPS (TTM) is -$4.28. In 2022 the company made an earnings per share (EPS) of -$5.86 an increase over its 2021 EPS that were of -$19.38.

EPS history for Tempest Therapeutics from 2021 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$3.91-33.34%
2022-$5.86-69.74%
2021-$19.38